These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33175259)

  • 1. ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event.
    La Mendola R; Bencivenga M; Torroni L; Sacco M; Giacopuzzi S
    Ann Surg Oncol; 2021 Jun; 28(6):3044-3045. PubMed ID: 33175259
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Effectiveness of Resection of Oligometastases from Esophageal Cancer.
    Ohkura Y
    Ann Surg Oncol; 2020 Mar; 27(3):660-661. PubMed ID: 31907746
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Surveillance for Early Detection of Tumor Recurrence after Esophagectomy in Patients with Esophageal Cancer.
    Takeuchi M; Kawakubo H; Matsuda S; Fukuda K; Nakamura R; Kitagawa Y
    Ann Surg Oncol; 2023 Apr; 30(4):2198-2199. PubMed ID: 36472782
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer.
    Wang HH; Plukker JTM; Hospers GAP
    Ann Surg Oncol; 2021 Jul; 28(7):3961-3962. PubMed ID: 33284429
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: The Impact of Preoperative Chemotherapy on Survival After Esophagectomy in Elderly Patients with Esophageal Cancer.
    Booka E; Haneda R; Ishii K; Tsubosa Y
    Ann Surg Oncol; 2021 Mar; 28(3):1796-1797. PubMed ID: 32860173
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: The Impact of Early Skeletal Muscle Loss Within 1 Week After Esophagectomy on Long-term Prognosis in Patients with Esophageal Cancer.
    Matsui K; Kawakubo H; Hirata Y; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
    Ann Surg Oncol; 2021 Oct; 28(11):6388-6389. PubMed ID: 33638046
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma.
    Kanie Y; Okamura A; Watanabe M
    Ann Surg Oncol; 2021 Nov; 28(12):7997-7998. PubMed ID: 33860360
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Achieving Adequate Lymphadenectomy in Esophageal Cancer Resection.
    Schlick CJR; Bentrem DJ
    Ann Surg Oncol; 2020 Oct; 27(11):4457-4458. PubMed ID: 32409971
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Establishment of an Ideal Criterion for Evaluating the Therapeutic Effect on Esophageal Cancer.
    Yoshida N; Eto K; Baba H
    Ann Surg Oncol; 2021 Dec; 28(13):8483-8484. PubMed ID: 34318386
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: The Impact of Minimally Invasive McKeown on Survival in Patients with Resectable Esophageal Cancer.
    Zheng Y; Xing W
    Ann Surg Oncol; 2021 Oct; 28(11):6337-6338. PubMed ID: 33939049
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Actual Sarcopenia in Esophageal Cancer Patients.
    Watanabe A; Oshikiri T
    Ann Surg Oncol; 2022 Jun; 29(6):3682. PubMed ID: 35066719
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Opting for a Cost-Effective Treatment Allocation in Patients with Esophageal Cancer.
    Gao X; van Lanschot JJ; Chao YK
    Ann Surg Oncol; 2022 Jun; 29(6):3654-3655. PubMed ID: 35024994
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Cervicothoracoscopic Esophagectomy for Esophageal Cancer.
    Takahashi K; Okamura A; Watanabe M
    Ann Surg Oncol; 2020 May; 27(5):1531-1532. PubMed ID: 32124122
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Postoperative Chylothorax After Radical Subtotal Esophagectomy.
    Ohkura Y
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):705-706. PubMed ID: 30255367
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Prediction of Pathological Features of Esophageal Cancer Using FDG-PET.
    Hamai Y
    Ann Surg Oncol; 2020 Oct; 27(11):4431-4432. PubMed ID: 32436192
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Can Perioperative Ghrelin Administration Inhibit Postoperative Muscle Mass Loss in Esophageal Cancer Patients?
    Nose Y; Yamashita K; Takeoka T; Momose K; Saito T; Tanaka K; Yamamoto K; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Shiraishi O; Miyata H; Yasuda T; Yano M; Eguchi H; Doki Y
    Ann Surg Oncol; 2022 Jun; 29(6):3613-3614. PubMed ID: 35166955
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Esophagectomy Versus Nonsurgical Treatment for Resectable Esophageal Cancer.
    Ohkura Y
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):703-704. PubMed ID: 30251022
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma.
    Kang CH; Hwang Y; Lee HJ; Park IK; Kim YT
    Ann Thorac Surg; 2016 Oct; 102(4):1074-80. PubMed ID: 27302078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflections: The Role of Robot-Assisted Ivor Lewis Esophagectomy for Esophageal Cancer.
    Zhang Y; Li H
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):594-595. PubMed ID: 31025227
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Significance of Skeletal Muscle Loss After Esophagectomy for Esophageal Cancer.
    Nakashima Y; Mori M
    Ann Surg Oncol; 2020 Feb; 27(2):499. PubMed ID: 31754911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.